Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial.
Sanjay BasuSridharan RaghavenDeborah J WexlerSeth A BerkowitzPublished in: Diabetes care (2017)
Age, BMI, and HGI may help individualize prediction of the benefit and harm from intensive glycemic therapy.